Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRRO | ACRV | RFL | ||
| Company | Korro Bio Inc | Acrivon Therapeutics Inc | Rafael Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 7.86 | 2.63 | 1.5000 | ||
| High | 8.83 | 2.72 | 1.5400 | ||
| Low | 7.78 | 2.51 | 1.4350 | ||
| Latest | 8.23 | 2.53 | 1.4600 | ||
| Change | +0.33 | -0.08 | -0.0300 | ||
| % Change | +4.18% | -3.07% | -2.01% | ||
| Volume | 384,400 | 364,800 | 135,500 | ||
| 20-Day Average Volume | 616,890 | 535,975 | 143,205 | ||
| Previous Close | 7.90 | 2.61 | 1.4900 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.46 | 2.39 | 1.2880 | ||
| 20-Day Raw Stochastic | 83.45% | 72.60% | 67.44% | ||
| 20-Day Relative Strength | 33.38 | 59.13 | 59.99 | ||
| Weighted Alpha | -16.94 | +6.23 | -24.93 | ||
| Today's Opinion | 24% Sell | 88% Buy | 40% Sell | ||
| Previous Opinion | 24% Sell | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 40% Buy | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.24% since 12/05/25 | +6.75% since 12/05/25 | +18.70% since 12/05/25 | ||
| Low | 7.04 on 12/08/25 | 2.38 on 12/08/25 | 1.2200 on 12/08/25 | ||
| High | 8.83 on 12/12/25 | 2.73 on 12/11/25 | 1.6000 on 12/11/25 | ||
| 1-Month | |||||
| %Chg | -73.81% since 11/12/25 | +10.96% since 11/12/25 | +14.96% since 11/12/25 | ||
| Low | 5.20 on 12/02/25 | 2.00 on 11/14/25 | 1.1700 on 11/26/25 | ||
| High | 8.83 on 12/12/25 | 2.73 on 12/11/25 | 1.6000 on 12/11/25 | ||
| 3-Month | |||||
| %Chg | -73.24% since 09/12/25 | +66.45% since 09/12/25 | +8.96% since 09/12/25 | ||
| Low | 5.20 on 12/02/25 | 1.47 on 09/15/25 | 1.1700 on 11/26/25 | ||
| High | 55.89 on 10/16/25 | 2.73 on 12/11/25 | 1.7000 on 09/18/25 | ||
| 6-Month | |||||
| %Chg | -41.13% since 06/12/25 | +99.21% since 06/12/25 | -33.64% since 06/12/25 | ||
| Low | 5.20 on 12/02/25 | 1.15 on 07/01/25 | 1.1700 on 11/26/25 | ||
| High | 55.89 on 10/16/25 | 2.73 on 12/11/25 | 2.6494 on 07/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,504 | 79,834 | 75,586 | ||
| Shares Outstanding, K | 9,417 | 31,555 | 51,771 | ||
| Annual Sales | 2,270,000 | 0 | 920,000 | ||
| Annual Net Income | -83,580,000 | -80,560,000 | -30,520,000 | ||
| Last Quarter Sales | 1,090,000 | 0 | 350,000 | ||
| Last Quarter Net Income | -18,060,000 | -18,230,000 | -12,090,000 | ||
| 60-Month Beta | 3.03 | 1.75 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.92 on 11/12/25 | -0.47 on 11/13/25 | -0.28 on 10/29/25 | ||
| Latest Earnings Date | 03/17/26 | 03/26/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||